Symbols / AGL $0.58 -3.07%
AGL Chart
About
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Care Facilities | Market Cap | 241.25M |
| Enterprise Value | -7.08M | Income | -405.35M | Sales | 5.93B |
| Book/sh | 0.31 | Cash/sh | 0.69 | Dividend Yield | — |
| Payout | 0.00% | Employees | 856 | IPO | — |
| P/E | — | Forward P/E | -3.26 | PEG | — |
| P/S | 0.04 | P/B | 1.90 | P/C | — |
| EV/EBITDA | 0.02 | EV/Sales | -0.00 | Quick Ratio | 0.92 |
| Current Ratio | 1.02 | Debt/Eq | 29.05 | LT Debt/Eq | — |
| EPS (ttm) | -0.98 | EPS next Y | -0.18 | EPS Growth | — |
| Revenue Growth | 3.10% | Earnings | 2026-05-05 | ROA | -17.51% |
| ROE | -135.64% | ROIC | — | Gross Margin | -2.70% |
| Oper. Margin | -9.96% | Profit Margin | -6.60% | Shs Outstand | 414.87M |
| Shs Float | 270.63M | Short Float | 9.52% | Short Ratio | 2.68 |
| Short Interest | — | 52W High | 6.08 | 52W Low | 0.34 |
| Beta | 0.11 | Avg Volume | 7.03M | Volume | 3.25M |
| Target Price | $0.94 | Recom | Hold | Prev Close | $0.60 |
| Price | $0.58 | Change | -3.07% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$0.94
Mean price target
2. Current target
$0.58
Latest analyst target
3. DCF / Fair value
$-3.52
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.58
Low
$0.25
High
$2.00
Mean
$0.94
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-03 | main | Citigroup | Neutral → Neutral | $1 |
| 2026-02-27 | main | Wells Fargo | Overweight → Overweight | $2 |
| 2026-02-27 | main | Barclays | Underweight → Underweight | $1 |
| 2025-11-06 | main | Barclays | Underweight → Underweight | $1 |
| 2025-11-05 | main | Wells Fargo | Overweight → Overweight | $1 |
| 2025-10-07 | main | Wells Fargo | Overweight → Overweight | $2 |
| 2025-08-20 | down | Bernstein | Outperform → Market Perform | $1 |
| 2025-08-15 | main | Jefferies | Hold → Hold | $1 |
| 2025-08-14 | main | Baird | Neutral → Neutral | $1 |
| 2025-08-06 | main | Benchmark | Buy → Buy | $2 |
| 2025-08-06 | main | Barclays | Underweight → Underweight | $2 |
| 2025-08-06 | down | Citigroup | Buy → Neutral | $1 |
| 2025-07-09 | main | Evercore ISI Group | In-Line → In-Line | $3 |
| 2025-05-29 | main | Bernstein | Outperform → Outperform | $8 |
| 2025-05-13 | main | Wells Fargo | Overweight → Overweight | $5 |
| 2025-05-08 | main | Barclays | Underweight → Underweight | $3 |
| 2025-05-08 | main | Goldman Sachs | Neutral → Neutral | $5 |
| 2025-04-28 | reit | JMP Securities | Market Perform → Market Perform | — |
| 2025-04-25 | up | Citigroup | Neutral → Buy | $5 |
| 2025-04-15 | main | TD Cowen | Hold → Hold | $6 |
News
RSS: Latest AGL news- Why agilon health (AGL) Stock Is Down Today - Yahoo Finance Sat, 07 Mar 2026 00
- $AGL stock is down 16% today. Here's what we see in our data. - Quiver Quantitative Fri, 06 Mar 2026 19
- Why agilon health (AGL) Stock Is Trading Lower Today - The Globe and Mail Fri, 27 Feb 2026 08
- Why Is agilon health (AGL) Stock Soaring Today - The Globe and Mail hu, 26 Feb 2026 08
- $AGL stock is up 19% today. Here's what we see in our data. - Quiver Quantitative Wed, 25 Feb 2026 19
- Why agilon health (AGL) Shares Are Plunging Today - Yahoo Finance Fri, 05 Dec 2025 08
- Insider Purchase: Chief Markets Officer of $AGL Buys 500,000 Shares - Quiver Quantitative ue, 03 Mar 2026 22
- Why agilon health (AGL) Shares Are Getting Obliterated Today - Yahoo Finance Fri, 07 Nov 2025 08
- AGILON HEALTH ($AGL) Releases Q4 2025 Earnings - Quiver Quantitative Wed, 25 Feb 2026 22
- agilon health (AGL) Shares Skyrocket, What You Need To Know - Yahoo Finance ue, 06 Jan 2026 08
- Why agilon health (AGL) Stock Is Trading Lower Today - Yahoo Finance ue, 23 Dec 2025 08
- Why agilon health (AGL) Stock Is Falling Today - Yahoo Finance ue, 05 Aug 2025 07
- Why Is agilon health (AGL) Stock Soaring Today - Yahoo Finance Mon, 18 Aug 2025 07
- 3 of Wall Street’s Favorite Stocks We Steer Clear Of - StockStory hu, 05 Mar 2026 15
- Insider Purchase: Director at $AGL Buys 81,000 Shares | AGL Stock News - Quiver Quantitative Sat, 31 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 500000 | 301050 | — | Purchase at price 0.60 per share. | SHAKER BENJAMIN | Officer | — | 2026-03-02 00:00:00 | D |
| 1 | 600000 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHWANEKE JEFFREY A | Chief Financial Officer | — | 2026-01-09 00:00:00 | D |
| 2 | 81000 | 50941 | — | Purchase at price 0.63 per share. | WULF JOHN WILLIAM | Director | — | 2025-11-12 00:00:00 | D |
| 3 | 78724 | — | — | Stock Award(Grant) at price 0.00 per share. | WILLIAMS RONALD A | Director | — | 2025-05-28 00:00:00 | D |
| 4 | 78724 | — | — | Stock Award(Grant) at price 0.00 per share. | MANSUKANI SHARAD S. | Director | — | 2025-05-28 00:00:00 | D |
| 5 | 78724 | — | — | Stock Award(Grant) at price 0.00 per share. | MCLOUGHLIN KAREN | Director | — | 2025-05-28 00:00:00 | D |
| 6 | 78724 | — | — | Stock Award(Grant) at price 0.00 per share. | MCKENZIE DIANA L | Director | — | 2025-05-28 00:00:00 | D |
| 7 | 78724 | — | — | Stock Award(Grant) at price 0.00 per share. | BATTAGLIA SILVANA | Director | — | 2025-05-28 00:00:00 | D |
| 8 | 78724 | — | — | Stock Award(Grant) at price 0.00 per share. | WULF JOHN WILLIAM | Director | — | 2025-05-28 00:00:00 | D |
| 9 | 428922 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHWANEKE JEFFREY A | Chief Financial Officer | — | 2025-04-01 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -7.58M | -755.16K | 0.00 | -1.15M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.21 |
| NormalizedEBITDA | -332.78M | -214.59M | -167.64M | -66.96M |
| TotalUnusualItems | -36.09M | -3.60M | 0.00 | -5.46M |
| TotalUnusualItemsExcludingGoodwill | -36.09M | -3.60M | 0.00 | -5.46M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -405.35M | -250.33M | -195.05M | -92.00M |
| ReconciledDepreciation | 28.59M | 24.46M | 20.16M | 13.77M |
| ReconciledCostOfRevenue | 6.09B | 6.06B | 4.24B | 2.27B |
| EBITDA | -368.86M | -218.19M | -167.64M | -72.41M |
| EBIT | -397.45M | -242.65M | -187.80M | -86.19M |
| NetInterestIncome | -6.64M | -6.18M | -6.66M | -4.48M |
| InterestExpense | 6.64M | 6.18M | 6.66M | 4.48M |
| NormalizedIncome | -376.84M | -247.49M | -195.05M | -87.69M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -391.35M | -260.15M | -262.60M | -106.55M |
| TotalExpenses | 6.36B | 6.35B | 4.55B | 2.49B |
| TotalOperatingIncomeAsReported | -463.24M | -292.13M | -232.13M | -105.38M |
| DilutedAverageShares | 410.97M | 408.92M | 408.15M | 372.93M |
| BasicAverageShares | 410.97M | 408.92M | 408.15M | 372.93M |
| DilutedEPS | -0.63 | -0.64 | -0.26 | -1.09 |
| BasicEPS | -0.63 | -0.64 | -0.26 | -1.09 |
| DilutedNIAvailtoComStockholders | -391.35M | -260.15M | -262.60M | -106.55M |
| NetIncomeCommonStockholders | -391.35M | -260.15M | -262.60M | -106.55M |
| NetIncome | -391.35M | -260.15M | -262.60M | -106.55M |
| MinorityInterests | 0.00 | -50.00K | 207.00K | 311.00K |
| NetIncomeIncludingNoncontrollingInterests | -391.35M | -260.10M | -262.80M | -106.86M |
| NetIncomeDiscontinuousOperations | 14.00M | -9.82M | -67.55M | -14.55M |
| NetIncomeContinuousOperations | -405.35M | -250.28M | -195.25M | -92.31M |
| TaxProvision | 1.25M | 1.45M | 791.00K | 1.64M |
| PretaxIncome | -404.10M | -248.83M | -194.46M | -90.67M |
| OtherIncomeExpense | 29.70M | 45.88M | 44.33M | 19.19M |
| OtherNonOperatingIncomeExpenses | 67.62M | 34.49M | 27.84M | 13.93M |
| SpecialIncomeCharges | -36.09M | -3.60M | 0.00 | -5.46M |
| OtherSpecialCharges | 5.46M | |||
| WriteOff | 36.09M | 3.60M | 0.00 | 0.00 |
| EarningsFromEquityInterest | -1.83M | 14.99M | 16.49M | 10.72M |
| NetNonOperatingInterestIncomeExpense | -6.64M | -6.18M | -6.66M | -4.48M |
| InterestExpenseNonOperating | 6.64M | 6.18M | 6.66M | 4.48M |
| OperatingIncome | -427.15M | -288.53M | -232.13M | -105.38M |
| OperatingExpense | 267.13M | 293.38M | 301.80M | 216.74M |
| DepreciationAmortizationDepletionIncomeStatement | 28.59M | 24.46M | 16.04M | 8.95M |
| DepreciationAndAmortizationInIncomeStatement | 28.59M | 24.46M | 16.04M | 8.95M |
| SellingGeneralAndAdministration | 238.54M | 268.91M | 285.76M | 207.79M |
| GeneralAndAdministrativeExpense | 238.54M | 268.91M | 285.76M | 207.79M |
| OtherGandA | 238.54M | 268.91M | 285.76M | 207.79M |
| GrossProfit | -160.02M | 4.84M | 69.67M | 111.36M |
| CostOfRevenue | 6.09B | 6.06B | 4.25B | 2.28B |
| TotalRevenue | 5.93B | 6.06B | 4.32B | 2.39B |
| OperatingRevenue | 5.92B | 6.05B | 4.31B | 2.38B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 414.73M | 412.19M | 406.39M | 412.38M |
| ShareIssued | 414.73M | 412.19M | 406.39M | 412.38M |
| TotalDebt | 36.81M | 41.50M | 43.21M | 52.57M |
| TangibleBookValue | 61.01M | 374.05M | 573.94M | 1.02B |
| InvestedCapital | 161.72M | 505.86M | 694.15M | 1.08B |
| WorkingCapital | 20.21M | 305.77M | 502.92M | 916.18M |
| NetTangibleAssets | 61.01M | 374.05M | 573.94M | 1.02B |
| CapitalLeaseObligations | 1.83M | 6.60M | 10.90M | 9.09M |
| CommonStockEquity | 126.73M | 470.95M | 661.84M | 1.04B |
| TotalCapitalization | 142.48M | 505.86M | 694.15M | 1.08B |
| TotalEquityGrossMinorityInterest | 126.73M | 470.95M | 661.02M | 1.04B |
| MinorityInterest | 0.00 | -818.00K | -611.00K | -300.00K |
| StockholdersEquity | 126.73M | 470.95M | 661.84M | 1.04B |
| GainsLossesNotAffectingRetainedEarnings | 916.00K | -88.00K | -2.30M | -5.56M |
| OtherEquityAdjustments | 916.00K | -88.00K | -2.30M | -5.56M |
| RetainedEarnings | -1.98B | -1.59B | -1.33B | -1.06B |
| AdditionalPaidInCapital | 2.10B | 2.05B | 1.99B | 2.11B |
| CapitalStock | 4.15M | 4.12M | 4.06M | 4.12M |
| CommonStock | 4.15M | 4.12M | 4.06M | 4.12M |
| TotalLiabilitiesNetMinorityInterest | 1.14B | 1.26B | 1.08B | 656.86M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 68.07M | 111.03M | 102.69M | 121.77M |
| OtherNonCurrentLiabilities | 50.49M | 69.52M | 59.48M | 73.40M |
| LiabilitiesHeldforSaleNonCurrent | 0.00 | 794.00K | ||
| RestrictedCommonStock | 0.00 | |||
| NonCurrentDeferredLiabilities | 2.11M | |||
| NonCurrentDeferredTaxesLiabilities | 2.11M | |||
| LongTermDebtAndCapitalLeaseObligation | 17.58M | 41.50M | 43.21M | 47.57M |
| LongTermCapitalLeaseObligation | 1.83M | 6.60M | 10.90M | 9.09M |
| LongTermDebt | 15.75M | 34.90M | 32.31M | 38.48M |
| CurrentLiabilities | 1.08B | 1.15B | 977.16M | 535.09M |
| OtherCurrentLiabilities | 51.87M | |||
| CurrentDebtAndCapitalLeaseObligation | 19.24M | 6.25M | 5.00M | 5.00M |
| CurrentDebt | 19.24M | 6.25M | 5.00M | 5.00M |
| OtherCurrentBorrowings | 6.25M | 5.00M | ||
| PayablesAndAccruedExpenses | 1.06B | 1.15B | 977.16M | 478.23M |
| Payables | 1.06B | 1.15B | 977.16M | 478.23M |
| AccountsPayable | 1.06B | 1.15B | 977.16M | 478.23M |
| TotalAssets | 1.27B | 1.73B | 1.74B | 1.70B |
| TotalNonCurrentAssets | 174.59M | 276.21M | 260.79M | 246.19M |
| OtherNonCurrentAssets | 3.89M | 15.39M | 13.23M | 104.82M |
| NonCurrentPrepaidAssets | 2.08M | 2.05M | 2.05M | 1.73M |
| NonCurrentNoteReceivables | 14.16M | 63.16M | 71.86M | 69.38M |
| InvestmentsAndAdvances | 59.79M | 61.76M | 44.75M | 17.35M |
| LongTermEquityInvestment | 59.79M | 61.76M | 44.75M | 17.35M |
| GoodwillAndOtherIntangibleAssets | 65.72M | 96.90M | 87.90M | 20.96M |
| OtherIntangibleAssets | 65.72M | 72.77M | 63.77M | 18.45M |
| Goodwill | 0.00 | 24.13M | 24.13M | 2.51M |
| NetPPE | 28.96M | 36.95M | 40.99M | 31.95M |
| AccumulatedDepreciation | -35.54M | -24.68M | -14.32M | -9.00M |
| GrossPPE | 64.50M | 61.63M | 55.30M | 40.96M |
| OtherProperties | 4.53M | 10.76M | 15.39M | 14.01M |
| MachineryFurnitureEquipment | 59.97M | 50.87M | 39.92M | 26.95M |
| BuildingsAndImprovements | 2.00M | 1.71M | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 1.10B | 1.46B | 1.48B | 1.45B |
| OtherCurrentAssets | 137.76M | 35.14M | 42.51M | 31.57M |
| AssetsHeldForSaleCurrent | 0.00 | 39.52M | 0.00 | |
| RestrictedCash | 0.00 | 5.63M | 6.76M | 10.61M |
| PrepaidAssets | 18.97M | |||
| Receivables | 673.79M | 1.02B | 942.46M | 492.36M |
| AccountsReceivable | 673.79M | 1.02B | 942.46M | 492.36M |
| CashCashEquivalentsAndShortTermInvestments | 285.14M | 399.97M | 488.34M | 877.20M |
| OtherShortTermInvestments | 111.43M | 211.74M | 380.77M | 411.90M |
| CashAndCashEquivalents | 173.71M | 188.23M | 107.57M | 465.30M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -148.87M | -99.06M | -187.01M | -163.47M |
| RepurchaseOfCapitalStock | -2.99M | 0.00 | -200.00M | 0.00 |
| RepaymentOfDebt | 0.00 | -3.75M | -5.00M | -5.00M |
| IssuanceOfDebt | 0.00 | 0.00 | 100.00M | |
| IssuanceOfCapitalStock | 1.17M | 11.87M | 33.06M | 1.19B |
| CapitalExpenditure | -43.11M | -41.28M | -30.82M | -32.66M |
| InterestPaidSupplementalData | 5.66M | 4.60M | 5.80M | 3.67M |
| IncomeTaxPaidSupplementalData | 1.80M | 5.36M | 5.31M | 1.82M |
| EndCashPosition | 173.71M | 193.86M | 114.33M | 507.68M |
| BeginningCashPosition | 193.86M | 114.33M | 507.68M | 1.05B |
| ChangesInCash | -20.15M | 79.53M | -393.35M | -547.14M |
| FinancingCashFlow | -2.99M | -2.58M | -193.13M | 28.06M |
| CashFlowFromContinuingFinancingActivities | -2.99M | -2.58M | -193.13M | 28.06M |
| NetOtherFinancingCharges | -14.74M | |||
| ProceedsFromStockOptionExercised | 18.09M | |||
| NetCommonStockIssuance | -2.99M | 1.17M | -188.13M | 33.06M |
| CommonStockPayments | -2.99M | 0.00 | -200.00M | 0.00 |
| CommonStockIssuance | 1.17M | 11.87M | 33.06M | 1.19B |
| NetIssuancePaymentsOfDebt | 0.00 | -3.75M | -5.00M | -5.00M |
| NetLongTermDebtIssuance | 0.00 | -3.75M | -5.00M | -5.00M |
| LongTermDebtPayments | 0.00 | -3.75M | -5.00M | -5.00M |
| LongTermDebtIssuance | 0.00 | 0.00 | 100.00M | |
| InvestingCashFlow | 88.61M | 139.89M | -44.02M | -444.39M |
| CashFlowFromContinuingInvestingActivities | 88.61M | 139.89M | -44.02M | -444.39M |
| NetOtherInvestingChanges | -2.00M | -13.73M | -19.53M | -6.51M |
| NetInvestmentPurchaseAndSale | 133.72M | 194.91M | 49.38M | -405.72M |
| SaleOfInvestment | 193.87M | 206.91M | 164.04M | 52.55M |
| PurchaseOfInvestment | -60.15M | -12.01M | -114.66M | -458.26M |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | -43.06M | 500.00K |
| SaleOfBusiness | 0.00 | 0.00 | 2.19M | 500.00K |
| PurchaseOfBusiness | 0.00 | 0.00 | -45.25M | 0.00 |
| NetIntangiblesPurchaseAndSale | -29.87M | -28.03M | -14.98M | -17.23M |
| PurchaseOfIntangibles | -29.87M | -28.03M | -14.98M | -17.23M |
| NetPPEPurchaseAndSale | -13.24M | -13.25M | -15.83M | -15.43M |
| PurchaseOfPPE | -13.24M | -13.25M | -15.83M | -15.43M |
| OperatingCashFlow | -105.76M | -57.78M | -156.20M | -130.81M |
| CashFlowFromContinuingOperatingActivities | -105.76M | -57.78M | -156.20M | -130.81M |
| DividendReceivedCFO | 0.00 | 3.34M | 0.00 | 0.00 |
| ChangeInWorkingCapital | 189.47M | 130.59M | -10.07M | -59.44M |
| ChangeInOtherCurrentLiabilities | -2.06M | -1.82M | -16.80M | -11.89M |
| ChangeInOtherCurrentAssets | -133.00K | 6.00K | -397.00K | -205.00K |
| ChangeInPayablesAndAccruedExpense | -87.48M | 198.58M | 473.61M | 173.45M |
| ChangeInPayable | -87.48M | 198.58M | 473.61M | 173.45M |
| ChangeInAccountPayable | -87.48M | 198.58M | 473.61M | 173.45M |
| ChangeInPrepaidAssets | -65.44M | 8.40M | -6.12M | -16.62M |
| ChangeInReceivables | 344.58M | -74.58M | -460.37M | -204.17M |
| OtherNonCashItems | -5.52M | 887.00K | -4.04M | 3.53M |
| StockBasedCompensation | 49.12M | 50.66M | 69.50M | 28.38M |
| AssetImpairmentCharge | 36.09M | 3.60M | 0.00 | 0.00 |
| DeferredTax | 0.00 | 0.00 | 532.00K | -3.23M |
| DeferredIncomeTax | 0.00 | 0.00 | 532.00K | -3.23M |
| DepreciationAmortizationDepletion | 28.59M | 24.46M | 20.16M | 13.77M |
| DepreciationAndAmortization | 28.59M | 24.46M | 20.16M | 13.77M |
| OperatingGainsLosses | -12.16M | -11.21M | 31.06M | -10.72M |
| EarningsLossesFromEquityInvestments | 1.83M | -14.99M | -16.49M | -10.72M |
| NetIncomeFromContinuingOperations | -391.35M | -260.10M | -262.80M | -106.86M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for AGL
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|